Tagged with France

Pharma Olivier Pilley, French GM of the Swiss-American biotech company with a pioneering computational approach to anti-cancer therapies, presents ARIAD’s fascinating R&D model, his optimistic assessment of the competitiveness of the French clinical research environment as well as his personal motivations for working in a rapidly growing biotech company. ARIAD’s niche is…

France The Director of the Social Security talks about the need to strengthen the sustainability of the French social security system, how France is attached to its unique system combining a high level of public coverage, with the strong involvement of the private sector, helping to provide access to innovation for…

France France spends 11.6% of its GDP on health. This is behind the USA (17.1%) but ahead of Germany (11.2%), Japan (10.2%), Denmark (11.2%), and the united Kingdom (8.8%). The growth in healthcare spending as a share of GDP that occurred in 2009 across all of these countries can be attributed chiefly…

France

France The National Health Insurance Fund for employees (CNAMTS) is in charge of the health insurance branch of the Social Security system’s general scheme and manages the network of local health insurance funds (CPAM). 60 million general scheme beneficiaries. 91% of the population is insured by CNAMTS which covers 86% of…

France In France, the ACOSS (central agency of social security funds) is in charge of the social security general scheme’s cash operations. It manages the The Union of Social Security contribution and family benefit collection organizations which collect social contributions. In 2014 it • managed 9.6 million contributor accounts • collected 474.4…

Pharma The head of Aspen sterile operations and managing director of Aspen NDB, reveals how their facility in France acts as the main platform for the group´s sterile business, a market with tremendous potential at the world level; how the factory has a particularly strong international exposure, exporting 75 percent of…

Pharma The CEO of Diaxonhit Group, a fully integrated French leader in in vitro diagnostics, discusses the company’s strategic focus on specialty vitro diagnostics, his perspective on the challenge of consolidation that the diagnostics industry faces, as well as his cautiously optimistic assessment of  French competitiveness in the pharmaceutical and life…

pharma The Vice President of Health and Medicine at Pierre and Marie Curie University (UPMC) and Director of the University’s Institute of Oncology reveals how the French social security system needs to look at how to evaluate real needs, why the patient has to become more involved in the decisionmaking process,…

pharma The Director of the CNCR and the person in charge of the industrial sector, talk about the fragmented nature of French clinical research funding, why when it comes to boosting France’s attractiveness as a clinical research destination, funding is the number one issue for hospitals and reveals how the number…

France Ultimate Solutions Corp is a leading packaging solutions provider for the life sciences industry in Puerto Rico. Yoel Rivera, president of Ultimate Solutions, discusses new inventions the company is designing and their great potential for the healthcare industry. What was the motivation for creating Ultimate Solutions, and how did you…

France The President of France’s Association for CROs (AFCROs) discusses the issues surrounding France’s clinical research sector and the actions that both the public and private sector need to take to maintain their competitiveness. He also discusses his company’s recent merger with Biostatem and their mission to internationalize. While France remains…